SCHEMBL4737802

SCHEMBL4737802

Clc1cc(Cl)c2c(c1)O2.OBO

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 13/20 0.69
ALDH1A1 P00352 4/20 0.39
TSHR P16473 4/20 0.39
HSD17B10 Q99714 3/20 0.39
CYP3A4 P08684 2/20 0.39
RECQL P46063 2/20 0.39
FLT1 P17948 1/20 0.35
HPGD P15428 2/20 0.34
CA12 O43570 1/20 0.32
CA9 Q16790 1/20 0.32
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
SLC22A2 O15244 1/20 0.31
SLC22A1 O15245 1/20 0.31
NR1I2 O75469 1/20 0.31
SLC22A3 O75751 1/20 0.31
EGFR P00533 1/20 0.31
LMNA P02545 1/20 0.31
TTR P02766 1/20 0.31
ESR1 P03372 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8952151 0.91 AHR (0.82) AHRALDH1A1TSHRHSD17B10CYP3A4
SCHEMBL8952194 0.83 AHR (0.78) AHRALDH1A1TSHRHSD17B10CYP3A4
SCHEMBL31696700 0.82 AHR (1.00) AHRALDH1A1TSHRHSD17B10CYP3A4
SCHEMBL9345588 0.82 AHR (1.00) AHRALDH1A1TSHRHSD17B10CYP3A4
SCHEMBL2884895 0.80 AHR (0.67) AHRALDH1A1TSHRHSD17B10CYP3A4
SCHEMBL30431628 0.78 AHR (0.70) AHRALDH1A1FLT1MAPK1
SCHEMBL8952199 0.78 AHR (0.64) AHRALDH1A1TSHRHSD17B10CYP3A4
SCHEMBL8958639 0.78 AHR (0.70) AHRALDH1A1FLT1MAPK1
SCHEMBL7887922 0.77 AHR (0.74) AHRTSHRHSD17B10CYP3A4FLT1
SCHEMBL8952143 0.72 AHR (0.62) AHRALDH1A1FLT1CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008059368-A2 FUSED 2-AMINO PYRIMIDINE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCER PFIZER PRODUCTS INC. (US) 2008-05-22 WO disclosed